XML 68 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Financial Information (Parent Company Only) (Tables)
12 Months Ended
Dec. 31, 2023
Condensed Financial Information Disclosure [Abstract]  
Condensed Balance Sheets
Condensed Balance Sheets
December 31
2023
December 31
2022
Assets
Total cash and cash equivalents$79,749 $54,097 
Investment in subsidiaries765,299 748,983 
Other assets7,008 10,519 
Total assets$852,056 $813,599 
Liabilities
Subordinated notes$55,543 $58,896 
Junior subordinated debentures issued to capital trusts57,258 57,027 
Other liabilities20,443 20,301 
Stockholders’ Equity718,812 677,375 
Total liabilities and stockholders’ equity$852,056 $813,599 
Condensed Statements of Income
Condensed Statements of Income
Years Ended December 31
202320222021
Operating Income (Expense)
Dividend income from subsidiaries$55,500 $34,750 $22,500 
Interest expense(8,226)(6,258)(5,767)
Other income431 45 25 
Salaries and employee benefits(3,502)(2,551)(1,890)
Other expense(370)(411)(591)
Income Before Undistributed Income (Dividends in Excess) of Subsidiaries43,833 25,575 14,277 
Undistributed income (dividends in excess) of subsidiaries(17,838)66,473 71,439 
Income Before Tax25,995 92,048 85,716 
Income tax benefit1,986 1,360 1,375 
Net Income Available to Common Shareholders$27,981 $93,408 $87,091 
Condensed Statements of Comprehensive Income (Loss)
Condensed Statements of Comprehensive Income (Loss)
Years Ended December 31
202320222021
Net Income$27,981 $93,408 $87,091 
Other Comprehensive Income (Loss)
Change in fair value of derivative instruments:
Change in fair value of derivative instruments for the period(523)5,649 4,570 
Reclassification adjustment for swap termination gain realized in income(1,453)— — 
Income tax effect415 (1,186)(960)
Changes from derivative instruments(1,561)4,463 3,610 
Change in securities:
Unrealized gain (loss) for the period on available for sale securities20,728 (147,345)(35,547)
Reclassification of gain (loss) from available for sale securities to held to maturity securities— (794)5,869 
Amortization (accretion) from transfer of securities from available for sale to held to maturity securities(691)(1,236)66 
Reclassification adjustment for securities (gains) losses realized in income32,052 — (914)
Income tax effect(10,939)31,369 6,409 
Unrealized gains (losses) on securities41,150 (118,006)(24,117)
Other Comprehensive Income (Loss), Net of Tax39,589 (113,543)(20,507)
Comprehensive Income (Loss)$67,570 $(20,135)$66,584 
Condensed Statements of Cash Flows
Condensed Statements of Cash Flows
Years Ended December 31
202320222021
Operating Activities
Net income$27,981 $93,408 $87,091 
Items not requiring (providing) cash
Dividends in excess (equity in undistributed net income) of subsidiaries17,838 (66,473)(71,439)
Change in:
Share based compensation3,586 2,475 1,819 
Other assets7,184 (284)730 
Other liabilities(413)120 946 
Net cash provided by operating activities56,176 29,246 19,147 
Investing Activities
Capital contribution to subsidiary— — (60,000)
Other investing activities1,762 — — 
Net cash used in investing activities1,762 — (60,000)
Financing Activities
Other change in borrowings378 388 384 
Repurchase of outstanding stock— — (7,607)
Dividends paid on common shares(28,311)(27,765)(24,768)
Net settlement of share awards(1,221)(1,824)(1,355)
Stock option exercises— 145 1,062 
Repayment of subordinated notes(3,132)— — 
Net cash used in financing activities(32,286)(29,056)(32,284)
Net Change in Cash and Cash Equivalents25,652 190 (73,137)
Cash and Cash Equivalents at Beginning of Year54,097 53,907 127,044 
Cash and Cash Equivalents at End of Year$79,749 $54,097 $53,907